Trial Profile
Observational Study on Evaluation of Glycaemic Control in Patients Using Levemir (Insulin Detemir) as Initiation Insulin Therapy by Levemir (Insulin Detemir) Administered 1 (Once) Daily as the Treatment of Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms START
- Sponsors Novo Nordisk
- 19 Apr 2011 Actual patient numbers reported as 2188 by the Clinicaltrials.gov record
- 19 Apr 2011 Status changed from active, no longer recruiting to completed, as reported by the ClinicalTrials.gov record
- 24 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.